| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Observational Study |
| Article Title |
Evaluation of hybrid closed-loop insulin delivery system in type 1 diabetes in real-world clinical practice: One-year observational study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ahmed Eldib, Shilton Dhaver, Karim Kibaa, Astrid Atakov-Castillo, Tareq Salah, Marwa Al-Badri, Abdelrahman Khater, Ryan McCarragher, Omnia Elenani, Elena Toschi and Osama Hamdy |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Tareq Salah, MD, Research Fellow, Department of Clinical, Behavioral & Outcomes Research, Joslin Diabetes Center, No. 1 Joslin Place, Boston, MA 02215, United States. tareq.salah@joslin.harvard.edu |
| Key Words |
Artificial pancreas; Continuous blood glucose monitor; Type 1 diabetes; Hybrid closed-loop insulin delivery; Quality of life |
| Core Tip |
There has been a growing emphasis on patient-centered healthcare and there are limited data on the impact of hybrid-closed-loop systems on quality-of-life measures. In this study, we aimed to evaluate the glycemic control and quality of life measures in patients with type 1 diabetes in a real-world clinical practice who used hybrid closed loop systems showed improvements in A1C, percent time in optimal glucose range, emotional burden and distress due to diabetes, physical functioning, and fear of hypoglycemia. |
| Publish Date |
2024-03-15 09:49 |
| Citation |
Eldib A, Dhaver S, Kibaa K, Atakov-Castillo A, Salah T, Al-Badri M, Khater A, McCarragher R, Elenani O, Toschi E, Hamdy O. Evaluation of hybrid closed-loop insulin delivery system in type 1 diabetes in real-world clinical practice: One-year observational study. World J Diabetes 2024; 15(3): 455-462 |
| URL |
https://www.wjgnet.com/1948-9358/full/v15/i3/455.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v15.i3.455 |
